Validating Vaxxas

HealthCare Ventures, an early stage investor with a penchant for academic spinouts, recently made its first Australian investment in new vaccine company Vaxxas Pty Ltd.

The Cambridge, Mass., firm participated in Vaxxas' first venture round, which raised A$15 million ($16.6 million). The round was led by Australian VC OneVentures. Brandon Capital Partners; the Medical Research Commercialization Fund (MRCF); and the Brisbane Angels also participated...